Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Another market introduction for Xalatan

May 18, 1998

Verteporfin proven safe in phase III trials

May 15, 1998

Vitrase shown to clear vitreous hemorrhage

May 15, 1998

Akorn launches generic cromolyn sodium

May 12, 1998

VISX Excimer Laser System approved in Japan

May 11, 1998

Novo Nordisk discovers potent sst4 receptor agonist

May 5, 1998

First market introduction for Alcon's newest ophthalmic drug

May 5, 1998

Update on Repligen's angiogenesis inhibitors

May 1, 1998

CyDex and Allergan sign option for ophthalmic drug delivery technology

April 29, 1998

New antiglaucoma agent approved in U.S.

April 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...